packageMomelotinib

momelotinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Momelotinib is a kinase inhibitor used to treat myelofibrosis. It is authorised in the European Union for myeloproliferative disorders such as splenomegaly.

Summary written by glm-5.3-flash from Wikidata Q252602 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:momelotinib
ATC codes:L01EJ04
DrugBank:DB11763
PubChem CID:25062766
ChEBI:91407
Wikidata:Q252602
formula:C23H22N6O2
molar mass:414.469 g/mol (PubChem CID 25062766)
logP:2.6 (Drugs.Common 25.09, not verified)

Metabolites

M21M21molar mass unknown

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
M21metabolite: M21